The indusium griseum in Alzheimer's disease: an immunocytochemical study.

Abstract

The immunocytochemical features of the indusium griseum (IG) were compared with the corresponding hippocampus in 5 patients with Alzheimer's disease (AD) and 5 age-matched nondemented individuals using antibodies against beta-amyloid, the A68 protein (Alz-50 antibody), tau, ubiquitin and synapsin I. beta-Amyloid-positive plaques were prominent in the AD hippocampus but were not present in the IG. Numerous Alz-50, tau and ubiquitin-positive neurofibrillary tangles and dystrophic neurites were observed in the AD hippocampus but were infrequent in the IG. Synapsin I immunoreactivity was significantly reduced in both the AD hippocampus and the AD IG when compared to age-matched patients. These findings suggest that the IG may be resistant to factors that trigger production of abnormal AD-associated proteins. Loss of synaptic input alone may not account for the AD-associated changes in the hippocampus since synaptic depletion was seen in both the hippocampus and the unaffected AD IG.

Statistics

0500'95'98'01'04'07'10'13'16
Citations per Year

1,297 Citations

Semantic Scholar estimates that this publication has 1,297 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Lippa1992TheIG, title={The indusium griseum in Alzheimer's disease: an immunocytochemical study.}, author={Carol F Lippa and Thomas Smith}, journal={Journal of the neurological sciences}, year={1992}, volume={111 1}, pages={39-45} }